Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ERAS-601 |
| Trade Name | |
| Synonyms | ERAS 601|ERAS601 |
| Drug Descriptions |
ERAS-601 inhibits SHP2, potentially resulting in decreased cell growth and inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2669). |
| DrugClasses | SHP2 Inhibitor 20 |
| CAS Registry Number | NA |
| NCIT ID | C176881 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Adagrasib + ERAS-601 | Adagrasib ERAS-601 | 0 | 0 |
| Cetuximab + ERAS-601 | Cetuximab ERAS-601 | 0 | 0 |
| ERAS-007 + ERAS-601 | ERAS-007 ERAS-601 | 0 | 0 |
| ERAS-601 | ERAS-601 | 0 | 2 |
| ERAS-601 + Gilteritinib | ERAS-601 Gilteritinib | 1 | 0 |
| ERAS-601 + Sotorasib | ERAS-601 Sotorasib | 0 | 1 |